Physician profile
Vito Alamia
NPI 1801973193
$2,671.91
in general payments reported to CMS, 2019-2025
29 companies · $611 in 2025
The $611 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $135 · 2022: $284 · 2023: $657 · 2024: $393 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $339.07 | 2019-2025 | Thinprep 2000 Processor |
| Amgen INC. | $264.78 | 2019-2025 | Evenity |
| Abbvie INC. | $259.85 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $186.61 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $182.67 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $149.61 | 2020-2025 | Paragard T 380a, Mara Console, Paragard T 380a |
| Biogen, INC. | $143.25 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $128.98 | 2019-2024 | Veozah |
| Meditrina | $118.77 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.42 | 2020-2025 | |
| Pfizer INC. | $81.62 | 2019-2025 | |
| Millicent US INC | $79.59 | 2024-2025 | Femlyv, Intrarosa |
| Shield Therapeutics INC | $68.60 | 2023-2025 | Accrufer |
| Ethicon US, LLC | $66.94 | 2019-2025 | Vistaseal, Dermabond, Stratafix |
| Merck Sharp & Dohme LLC | $65.65 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $58.30 | 2019 | |
| Therapeuticsmd, INC. | $46.76 | 2019 | |
| Organon LLC | $40.89 | 2023 | Nexplanon |
| Boston Scientific Corporation | $40.24 | 2025 | Bulkamid |
| Medtronic, INC. | $40.22 | 2023 | V-Loc 180, Sonicision |
| Axonics, INC. | $35.23 | 2023 | Bulkamid |
| Mayne Pharma Commercial LLC | $31.10 | 2025 | |
| Daiichi Sankyo INC. | $29.74 | 2019 | |
| Myovant Sciences INC. | $29.57 | 2022 | |
| Exact Sciences Corporation | $26.11 | 2025 | Cologuard Collection Kit |
| Urovant Sciences INC | $22.52 | 2022 | |
| Roche Diagnostics Corporation | $18.74 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.84 | 2019 | |
| Conmed Corporation | $15.24 | 2025 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vito Alamia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.